Alector (ALEC) Retained Earnings (2018 - 2026)
Alector's (ALEC) quarterly Retained Earnings came in at -$104000.0 in Q1 2026, up 99.99% year-on-year from -$52003.1 in Q1 2025, and up 99.99% on a QoQ basis from -$972.1 million in Q4 2025.
Alector (ALEC) Retained Earnings (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Retained Earnings data on file, last reported at -$104000.0 in Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.99% year-over-year to -$104000.0 in Q1 2026; TTM through Mar 2026 was -$104000.0, a 99.99% increase from a year earlier, with the FY2025 full-year figure at -$972.1 million, down 17.24% from the prior year.
- Retained Earnings for Q1 2026 stood at -$104000.0, up from -$972.1 million in the prior quarter.
- Over the last five years, Retained Earnings for ALEC reached as high as $992.3 million in Q3 2025 and fell as low as -$972.1 million in Q4 2025.
- Historically, Retained Earnings has averaged -$129.0 million across 5 years, with a median of -$2.2 million in 2023.
- Across the five-year window, Retained Earnings sank 450712.5% in 2024 and jumped 106483.67% in 2025, its largest moves.
- Year by year, Retained Earnings stood at $798.7 million in 2022, then plunged by 99.98% to $184000.0 in 2023, then sank by 450712.5% to -$829.1 million in 2024, then slipped by 17.24% to -$972.1 million in 2025, then surged by 99.99% to -$104000.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$104000.0 in Q1 2026, -$972.1 million in Q4 2025, and $992.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | -104,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -104,000.00 |
| Dec 31, 2025 | -972.06 Mn |
| Sep 30, 2025 | 992.29 Mn |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | -869.60 Mn |
| Dec 31, 2024 | -829.13 Mn |
| Sep 30, 2024 | 931,000.00 |
| Jun 30, 2024 | -784.83 Mn |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | 184,000.00 |
| Sep 30, 2023 | -668.64 Mn |
| Jun 30, 2023 | -624.17 Mn |
| Mar 31, 2023 | -2.20 Mn |
| Dec 31, 2022 | 798.70 Mn |
| Sep 30, 2022 | -6.74 Mn |
| Jun 30, 2022 | 775.84 Mn |
| Mar 31, 2022 | -3.94 Mn |
| Dec 31, 2021 | -943,000.00 |
| Sep 30, 2021 | 726.69 Mn |
| Jun 30, 2021 | -517.37 Mn |